ES8704930A1 - Procedimiento de preparar derivados de acidos carboxilicos substituidos - Google Patents

Procedimiento de preparar derivados de acidos carboxilicos substituidos

Info

Publication number
ES8704930A1
ES8704930A1 ES550689A ES550689A ES8704930A1 ES 8704930 A1 ES8704930 A1 ES 8704930A1 ES 550689 A ES550689 A ES 550689A ES 550689 A ES550689 A ES 550689A ES 8704930 A1 ES8704930 A1 ES 8704930A1
Authority
ES
Spain
Prior art keywords
radical
oxoquinoline
pyrrol
dihydro
fluoro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES550689A
Other languages
English (en)
Other versions
ES550689A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Provesan SA
Original Assignee
Provesan SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provesan SA filed Critical Provesan SA
Publication of ES8704930A1 publication Critical patent/ES8704930A1/es
Publication of ES550689A0 publication Critical patent/ES550689A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyrrole Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DE ACIDOS CARBOXILICOS, DE FORMULA (I). COMPRENDE LA REACCION DE UN COMPUESTO DE FORMULA (II) CON EL HALOGENURO DE ALQUILO ADECUADO; SEGUIDA DE HIDROLISIS ALCALINA DEL PRODUCTO FORMADO; Y, FINALMENTE ACIDIFICACION PARA OBTENER EL COMPUESTO DE FORMULA (I), EN LA QUE R PUEDE SER VARIOS TIPOS DE RADICALES. LA ALQUILACION SE EFECTUA EN UN DISOLVENTE INERTE, EN PRESENCIA DE UNA BASE, A UNA TEMPERATURA ENTRE 60JC Y 90JC. ESTOS COMPUESTOS TIENEN APLICACIONES FARMACOLOGICAS POR SUS PROPIEDADES ANTIMICROBIANAS, ANTIBACTERIANAS Y FUNGISTATICAS.
ES550689A 1984-12-12 1985-12-12 Procedimiento de preparar derivados de acidos carboxilicos substituidos Expired ES8704930A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8419001A FR2574404B1 (fr) 1984-12-12 1984-12-12 Derives 1-substitues de l'acide 6-fluoro-7-(pyrrol-1-yl)-1,4-dihydro-4-oxoquinoleine-3-carboxylique, leur preparation et leur application en tant que medicaments

Publications (2)

Publication Number Publication Date
ES8704930A1 true ES8704930A1 (es) 1987-05-01
ES550689A0 ES550689A0 (es) 1987-05-01

Family

ID=9310528

Family Applications (1)

Application Number Title Priority Date Filing Date
ES550689A Expired ES8704930A1 (es) 1984-12-12 1985-12-12 Procedimiento de preparar derivados de acidos carboxilicos substituidos

Country Status (15)

Country Link
US (1) US4727080A (es)
EP (1) EP0187085B1 (es)
JP (1) JPS61197577A (es)
AT (1) ATE56446T1 (es)
CS (1) CS258136B2 (es)
DD (1) DD242042A5 (es)
DE (1) DE3579683D1 (es)
ES (1) ES8704930A1 (es)
FR (1) FR2574404B1 (es)
HU (1) HU195802B (es)
PL (1) PL146541B1 (es)
PT (1) PT81652B (es)
RO (1) RO93482B (es)
SU (1) SU1426453A3 (es)
YU (1) YU43691B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3519286A1 (de) * 1985-05-30 1986-12-04 Bayer Ag, 5090 Leverkusen 7-azolyl-1-cyclopropyl-1,4-dihydro-4-oxo-3- chinolincarbonsaeuren und -1,8-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
DE3606698A1 (de) * 1986-03-01 1987-09-03 Bayer Ag 7-(1-pyrrolidinyl)-chinoloncarbonsaeure -derivate
US5153204A (en) * 1986-03-01 1992-10-06 Bayer Aktiengesellschaft 7-(1-Pyrrolidinyl)-quinolonecarboxylic acid derivatives
DE3639465A1 (de) * 1986-11-18 1988-05-19 Hoechst Ag Optisch aktive gyrasehemmer, ihre herstellung und verwendung als antibiotika
FR2629456B1 (fr) * 1988-03-31 1991-07-05 Esteve Labor Dr Derives des acides 7-(1-imidazolyl),1,4-dihydro-4-oxo-6,8-difluoro-1-cyclopropyl-3-quinoleincarboxylique, leur preparation et leur application en tant que medicaments
US5039682A (en) * 1988-06-21 1991-08-13 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US5103040A (en) * 1988-06-21 1992-04-07 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
US5104868A (en) * 1988-06-21 1992-04-14 Pfizer Inc. Tricyclic derivatives of 7-substituted-6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acids and esters
US5233091A (en) * 1988-06-21 1993-08-03 Pfizer Inc. 6-fluoro-1,4-dihydroquinol-4-one-3-carboxylic acid derivatives and intermediates therefor
CA2058424A1 (en) * 1989-07-21 1991-01-22 Akihiro Shibata Quinoline carboxylic acid derivatives
WO2005019224A2 (en) * 2003-06-06 2005-03-03 Cadila Healthcare Limited Novel antiinfective compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1175836A (en) * 1977-09-20 1984-10-09 Marcel Pesson Production of 1,4-dihydroquinoline-3-carboxylic acid derivatives
DE3142854A1 (de) * 1981-10-29 1983-05-11 Bayer Ag, 5090 Leverkusen 1-cyclopropyl-6-fluor-1,4-dihydro-4-oxo-7-piperazino-chinolin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
SE440354B (sv) * 1981-02-19 1985-07-29 Kyorin Seiyaku Kk Kinolinkarboxylsyraderivat
US4499091A (en) * 1982-03-31 1985-02-12 Sterling Drug Inc. 1-Amino (or substituted amino)-1,4-dihydro-4-oxo-6-fluoro-7-heterylquinoline-3-carboxylic acids and their use as antibacterial agents
DE3248507A1 (de) * 1982-12-29 1984-07-05 Bayer Ag, 5090 Leverkusen Mikrobizide mittel auf chinoloncarbonsaeure basis
FR2559484B2 (fr) * 1983-07-06 1986-09-26 Provesan Sa Nouveau derive 7-(pyrrol-1-yl) de l'acide 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridin)-3-carboxylique, sa preparation et son application en tant que medicament
IT1221492B (it) * 1984-03-13 1990-07-06 Biochem Design Srl Acidi 7-(1-pirril)-e 7-(1-pirroli-dinil)-6-fluoro-1-etil-1,4-diidro-4-chetochinolin-3-carbossilici ad attivita' antimicrobiche,loro procedimento di preparazione e composti farmaceutici che li contengono
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
US4636506A (en) * 1984-12-06 1987-01-13 Pfizer, Inc. 7-heterocyclic-1,4-dihydroquinolones

Also Published As

Publication number Publication date
EP0187085A1 (fr) 1986-07-09
ES550689A0 (es) 1987-05-01
HUT40640A (en) 1987-01-28
PT81652A (fr) 1986-01-01
PL146541B1 (en) 1989-02-28
CS258136B2 (en) 1988-07-15
ATE56446T1 (de) 1990-09-15
RO93482B (ro) 1988-01-02
FR2574404A1 (fr) 1986-06-13
YU192385A (en) 1988-04-30
DE3579683D1 (de) 1990-10-18
PL256757A1 (en) 1986-10-07
SU1426453A3 (ru) 1988-09-23
JPS61197577A (ja) 1986-09-01
RO93482A (ro) 1987-12-31
PT81652B (pt) 1988-04-21
HU195802B (en) 1988-07-28
US4727080A (en) 1988-02-23
FR2574404B1 (fr) 1987-04-24
EP0187085B1 (fr) 1990-09-12
DD242042A5 (de) 1987-01-14
YU43691B (en) 1989-10-31
CS921385A2 (en) 1987-12-17
JPH0312064B2 (es) 1991-02-19

Similar Documents

Publication Publication Date Title
LU91076I9 (en) 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a derivatives
IL74707A (en) Anti-viral compositions comprising pyridazinamines,certain such novel compounds and their preparation
IL83684A (en) Fungicidal compositions containing arylcarboxylic acid derivatives,certain such compounds and their preparation
ES2018111A6 (es) Procedimiento de preparacion de derivados de 4h-1-benzopiran-4-ona o sus sales.
IL86551A (en) (1h-azol-1-ylmethyl)substituted benzotriazole derivatives,their preparation and pharmaceutical compositions containing them
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
IL107188A0 (en) Derivatives of quinolonecarboxylic acid and naphthyridonecarboxylic acid, their preparation and antibacterial compositions containing them
ES8704930A1 (es) Procedimiento de preparar derivados de acidos carboxilicos substituidos
IL102261A0 (en) 7-isoindolinyl-quinolone-and-naphthyridonecarboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
IL108571A0 (en) Derivatives of quinolonecarboxylic acid and naphthyrdionecarboxylic acid, their preparation and pharmaceutical compositions containing them
IL103293A0 (en) Substituted imidazolyl-propenoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL103292A0 (en) Cyclic-substituted imidazolyl-propenoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL95750A0 (en) Substituted anthranilic acid derivatives,their preparation and anthelmintic compositions containing them
ZA981430B (en) Anticancer composition
ZA933455B (en) Thiochroman compounds, processes for the preparation thereof and pharmaceutical compositions containing them
DE3062765D1 (en) 2-substituted-4-alkyl or trihaloalkyl-5-oxazolecarboxylic acid derivatives, their use as safening agents and herbicidal compositions containing them
IL68015A0 (en) Fungicidal compositions containing 2-cyano-3-amino-2-propenoic acid derivatives,certain such novel compounds and their preparation
CA2290557A1 (en) Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
IL102384A0 (en) 2-(imidazol-1-yl)-2-benzylethylidene-aminoxyalkanoic acid derivatives,their preparation and pharmaceutical compositions containing them
IL71068A0 (en) N-arylpiperazine derivative,its preparation and pharmaceutical compositions containing it
IL96932A0 (en) Substituted beta-pyrimidinyloxy-(thio)-and beta-triazinyloxy(thio)-cycloalkanecarboxylic acid derivatives and herbicidal compositions containing the same
IL70796A (en) Triazole derivatives,their preparation and pharmaceutical and agricultural compositions containing them
IL97402A0 (en) 5-phenyl-1h-pyrazol-4-propionic acid derivatives,their preparation and pharmaceutical compositions containing them
EP0509098A4 (en) Ataractic
IL105189A0 (en) Cycloalkyl-and heterocycyl-substituted imidazolylpropenoic acid derivatives,their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20061230